品牌价值网_中国品牌价值排行榜-Pfizer CEO: Two Vaccine Doses Aren’t Enough for Omicron
中国品牌价值评价标准

当前位置:首页 > 国际动态>正文

Pfizer CEO: Two Vaccine Doses Aren’t Enough for Omicron

2022-01-15 18:45:40    来源:Daguan Keweiwei

image.png


    According to foreign media, Pfizer CEO Albert Bourla said two doses of the company’s vaccine may not provide strong protection against infection from the omicron Covid variant, ,and the original shots have also lost some of their efficacy.


    Bourla said omicron is a more difficult target than previous variants. Omicron, which has dozens of mutations, can evade some of the protection provided by Pfizer’s original two shots.


    Real-world data from the United Kingdom has found that two vaccine doses are 52% effective at preventing hospitalization 25 weeks after receiving the second shot, according to data from the U.K. Health Security Agency.


    About Pfizer

image.png


    Pfizer, founded in 1849, has a history of more than 170 years. Headquartered in New York, it is a science-based, innovative and patient-oriented biopharmaceutical company. Pfizer's goal is to "bring breakthroughs and innovations to patients that change their lives".


    On the ranking of “The 2nd Daguan·Keweiwei World Brand Value Top 900" released on January 13, 2022, Pfizer's brand value was 1221.507 billion RMB, ranking the 6th.


文章最后图片.png

作者:Nan



相关新闻全部阅读

阅读下一篇

Facebook Delays Return to US Office Until March 28

According to foreign media, Facebook parent Meta Platforms said on Moday that it will delay employees’ return to U.S. offices until March 28 from Jan. 31.

返回首页
返回新闻页面